Market Place
Sourcing Support
All News #Library
Biotech
Quince Therapeutics To Join Investor Events In Dec 2025
24 Nov 2025 //
BUSINESSWIRE
Quince Therapeutics Updates Business & Reveals Q3 2025 Result
12 Nov 2025 //
BUSINESSWIRE
Quince Therapeutics` Virtual Investor Day on October 2, 2025
11 Sep 2025 //
PHARMAWEB
Quince Therapeutics to Present at H.C. Wainwright Conference
02 Sep 2025 //
PHARMAWEB
Quince Therapeutics Appoints Dr. Hassan Abolhassani to Board
10 Jul 2025 //
BUSINESSWIRE
Quince Therapeutics Closes $22M Private Placement
18 Jun 2025 //
BUSINESSWIRE
Quince Therapeutics Prices $22M Private Placement
12 Jun 2025 //
BUSINESSWIRE
Quince Therapeutics Reports Q1 2025 Financial Results
13 May 2025 //
BUSINESSWIRE
Quince Therapeutics to Present at Life Sciences Conference
30 Apr 2025 //
BUSINESSWIRE
Quince Therapeutics to Present at Jones Healthcare Conference
03 Apr 2025 //
BUSINESSWIRE
Quince Therapeutics to Present at Oppenheimer Healthcare Conference
05 Feb 2025 //
BUSINESSWIRE
Quince Receives Allowance for Ataxia-Telangiectasia Use Method
04 Feb 2025 //
BUSINESSWIRE
Quince Therapeutics Hosts Ataxia-Telangiectasia Investor Webinar
28 Jan 2025 //
BUSINESSWIRE
Quince Therapeutics Business & Reports Q3 2024 Financial Results
13 Nov 2024 //
BUSINESSWIRE
Quince Therapeutics Presents ATTeST Data at Ataxia Congress
12 Nov 2024 //
BUSINESSWIRE
Quince Presents ATTeST Phase 3 Safety Data at CNS Meeting
11 Nov 2024 //
BUSINESSWIRE
Quince Therapeutics to Participate at Upcoming Investor Conferences
14 Oct 2024 //
BUSINESSWIRE
Quince Therapeutics to Present at H.C. Wainwright Global Investment Conference
03 Sep 2024 //
BUSINESSWIRE
Quince Therapeutics Reports Q2 2024 Results And Business Update
13 Aug 2024 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.